Rapid Action Drug Alerts and Response (RADAR) quarterly report
April 2023
A Management Information Statistics publication for Scotland
- Published
- 25 April 2023
- Type
- Statistical report
- Author
- Public Health Scotland
Trends
Police drug trends bulletin
This bulletin contains photos of drugs.
This update provides information on cocaine and street benzodiazepines.
This information has been provided by Police Scotland’s STOP Unit to raise awareness of drug appearance and to demonstrate some of the substances present in Scotland’s drugs market.
Cocaine
STOP Unit (West) continue with their drug collection scheme in partnership with an events centre. At the conclusion of events, the STOP Unit are contacted and the drugs are collected for destruction.
If there are recoveries of significance, these will be sent for analysis and images obtained. There have been no significant recoveries of note requiring analysis, but, recently, the most commonly recovered drug has been cocaine hydrochloride (powder cocaine). This could simply reflect the demographic of those attending events.
Cocaine powder
The Scottish Police Authority Forensic Services laboratory have confirmed the street purity of cocaine to be slightly higher than that of last year.
Crack Cocaine
Crack cocaine (freebase cocaine) is regularly encountered throughout the West of Scotland, but cocaine hydrochloride is still the most common form of cocaine. Crack cocaine can vary in appearance, as shown below.
Visit NHS inform for more information on cocaine.
Street benzos
'Street benzos' is a term used to describe benzodiazepines that are unlicensed or illicitly produced.
Most common benzodiazepines
- The most commonly encountered street benzodiazepine tablet is still the white circular tablet marked ‘10’ on one side with a half score on the reverse, containing etizolam.
- We are now starting to see the regular occurrence of other active ingredients, such as bromazolam.
- Bromazolam is most commonly, but not exclusively, detected in small light blue/blue tablets marked ‘MSJ’ on one side with a half score on the reverse. (No images at present.)
Operation Borzoi continues to monitor the recovery of street benzodiazepine tablets in Scotland.
RADAR intelligence and reports
23 reports were validated by RADAR between 12 January and 4 April 2023.
A summary of validated reports is shown below for informational purposes.
These reports have been collected as part of intelligence gathering by RADAR.
Since July 2022, RADAR has validated over 50 reports of drug-related harms received through the reporting form and mailbox.
Emerging concerns
From these reports, several key trends have emerged. Over half of submissions report polydrug use – the use of more than one substance at a time. Mixing drugs increases the risk of drug harms and death, this includes mixing alcohol with other drugs.
RADAR is currently assessing the harms related to cocaine, benzodiazepines, pregabalin (and other fake medicines) and nitazene-type opioids.
Concern: Cocaine-related harms and increasing reports of crack cocaine use
Drug: Cocaine. A short-lasting stimulant drug.
Legal status: In the UK, cocaine is classified as a Class A drug under the Misuse of Drugs Act (1971).
Summary
- Cocaine and adverse effects associated with cocaine were the most common type of drug report for a specific substance to RADAR.
- Reports relate to the use of both cocaine powder and crack cocaine (two different forms of the same drug).
- Physical health harms described in reports included heart problems, respiratory issues, soft-tissue damage and rashes.
- Mental health harms described in reports included anxiety, depression and psychosis.
Further information
- Cocaine powder is a white, crystalline powder that is typically snorted, while crack cocaine is a rock-like substance that is typically smoked.
- When a drug is smoked, the effects are felt more quickly and are more intense and short-lived, than when snorted.
- Injecting cocaine increases risk and is linked to more harmful effects.
Concern: Benzodiazepine-related harms and increasing use of bromazolam
Drug: Bromazolam. A benzodiazepine, similar in structure to alprazolam. Benzodiazepines are a group of depressant drugs with sedative and anxiolytic (anti-anxiety) effects.
Legal status: In the UK, many benzodiazepines (including bromazolam) are classified as Class C drugs under the Misuse of Drugs Act (1971).
Summary
- Multiple reports submitted to RADAR related to ‘street benzos’. In particular, unexpected effects from drugs sold as diazepam and an increase in the availability of bromazolam.
- This is supported by toxicology data that shows a decrease in detections of etizolam and an increase in detections of bromazolam (and other novel benzodiazepines such as bromazepam, flubromazepam and gidazepam).
- Adverse benzodiazepine effects described in reports include drowsiness, confusion, memory problems and black-outs, impaired coordination and unconsciousness.
Further information
- The decrease in etizolam may be due to international control. In 2021, etizolam and alprazolam were controlled under the United Nations Convention on Psychotropic Substances (1971), increasing regulations on production and distribution. The increase in bromazolam detections may be due to its availability and its potential to be used as a substitute.
- As bromazolam is not licensed for medical use, all bromazolam is illicitly manufactured. It is common for bromazolam to be mis-sold as another drug (such as diazepam or etizolam) or contain unpredictable concentrations in each pill, increasing the likelihood of adverse reactions and overdose.
- Mixing benzodiazepines with other depressants, such as alcohol, gabapentinoids or opioids, can increase the risk of overdose and respiratory depression.
Concern: Counterfeit pregabalin linked to adverse effects
Drug: Pregabalin. A gabapentinoid drug with depressant effects. It can be prescribed as a medicine to treat epilepsy and nerve pain.
Legal status: In the UK, pregabalin is classified as a Class C drug under the Misuse of Drugs Act (1971).
Summary
- RADAR has received an increase in reports related to the use of non-prescribed pregabalin. We also received an alert on ‘capsules sold as pregabalin’ released by police in West Yorkshire. This was shared with the network for information. To receive future alerts, sign-up to the network.
- Reports described physical effects including dizziness, drowsiness and unconsciousness.
- Reports described psychological effects including confusion and memory problems.
- Although many reports of ‘fake drugs’ in the last quarter were linked to pregabalin, the trend of counterfeit or fake medicines extends beyond gabapentinoids with fake opioids and benzodiazepines also reported.
Further information
- Mixing pregabalin with other depressants such as alcohol, benzodiazepines or opioids, can increase the risk of overdose and respiratory depression.
- Illicitly manufactured drugs carry additional risks, as it may be contaminated with other substances or have unpredictable potency levels, increasing the likelihood of adverse reactions and overdose.
- Counterfeit pills can be designed to look identical to the real medication, but there are some potential signs that may indicate that a pill is fake, including differences in colour, size and shape compared to the real medication.
- The packaging may be made from lower-quality materials, have spelling or grammatical errors, or lack information such as dosage instructions, expiry dates, serial numbers and tamper-proof seals. Pills purchased from illegitimate sources or online marketplaces may be more likely to be counterfeit.
Concern: Nitazenes increasing in availability and detected in overdoses and deaths in Scotland
Drug: Nitazenes. A group of potent synthetic opioids.
Legal status: In the UK, clonitazene and etonitazene are classified as Class A drugs under the Misuse of Drugs Act (1971). In February 2023, the UK government announced 10 other nitazenes will soon be controlled as Class A drugs.
Summary
- Reports to RADAR indicate an increase in the availability of a new group of drugs called nitazenes, including N-pyrrolidino-etonitazene (etonitazepyne or NPE), metonitazene and protonitazene.
Further information
- Due to their unexpected presence in the drug supply and high potency, nitazenes pose a substantial risk of overdose, drug-related hospitalisation and drug-related death.
- A public health alert on ‘nitazene-type opioids in Scotland’ was published on 24 January 2023 and updated on 29 March 2023.
Drug harm reports to RADAR
Shown below are 23 reports validated by RADAR between 12 January 2023 and 4 April 2023.
Please note, many of these reports have not been confirmed by toxicology and should be considered anecdotal.
Reports validated prior to 12 January, are shown in previous quarterly reports.
Report 1
Local authority: National
Reason for report: Adverse effects
Drug: Crack cocaine
Appearance: Unknown
Summary: Original report from Grampian but also similar reports from Glasgow, Fife and Dundee. Adverse effects from crack cocaine – skin irritation and rash on face, neck and body, particularly around the eyes and groin.
Report 2
Local authority: National
Reason for report: Alert
Drug: Pregabalin
Appearance: Red and white capsules with ‘signature’ branding
Summary: Alert from West Yorkshire police released after pregabalin capsules were suspected to be linked to multiple overdoses and hospitalisations.
Report 3
Local authority: Fife
Reason for report: Adverse effects
Drug: Crack cocaine
Appearance: Yellow crystal or rock, spongey in texture
Summary: Reports of adverse effects after smoking a ‘very small amount’ of crack, sold as ‘synthetic crack’ – chest pains, confusion, hallucinations, overheating, pale skin, panic, paranoia and slurred speech.
Report 4
Local authority: Edinburgh
Reason for report: Adverse effects
Drug: Pregabalin
Appearance: Unknown
Summary: Pregabalin (thought to be fake) reported to be very strong and causing seizures in seasoned users.
Report 5
Local authority: Edinburgh
Reason for report: New drug, adverse effects
Drug: Diazepam
Appearance: Pill stamped with ‘KB10’
Summary: Drug sold as diazepam or Valium suspected to be involved in deaths.
Report 6
Local authority: Stirling, Falkirk
Reason for report: New drug, adverse effects
Drug: Diazepam
Appearance: White, hexagonal pill
Summary: Separate patients reporting the presence of a white hexagonal ‘Valium’ referred to as ‘hulk’, causing adverse effects – days of black-out, no recall of previous day(s’) events and loss of consciousness. Reported as stronger than any other Valium they have previously ingested. Purchased as loose pills from a dealer in Glasgow.
Report 7
Local authority: East Lothian
Reason for report: Adverse effects
Drug: Diazepam
Appearance: White pill, stamped with letter 'Y' on tablet, small (similar to size of contraceptive pill)
Summary: Adverse effects after swallowing pills thought to be diazepam - unable to recall events (losing days), decreased energy and drowsiness. Purchased as loose pills for £1 per pill.
Report 8
Local authority: Edinburgh
Reason for report: Adverse effects
Drug: Crack cocaine
Appearance: Yellow rocks
Summary: Low priced, yellow crack cocaine causing serious side effects.
Report 9
Local authority: East Lothian
Reason for report: New trend, adverse effects
Drug: Codeine
Appearance: Unknown
Summary: Reports of young people drinking cough mixture with crushed up codeine.
Report 10
Local authority: Fife
Reason for report: New trend – changing drugs market
Drug: Diazepam
Appearance: Unknown
Summary: Use of online marketplaces to purchase drugs with buying incentives such as discounts and a range of payment options, including the use of bank transfers and cryptocurrencies.
Report 11
Local authority: Edinburgh
Reason for report: Adverse effects
Drug: Valium
Appearance: Unknown
Summary: Strong pills, sold as ‘Valium’, posing risk for inexperienced users, particularly in the homeless population.
Report 12
Local authority: Fife
Reason for report: New trend
Drug: Ketamine and cocaine
Appearance: White powder
Summary: Use of 'kit-kat' or ‘CK’ – ketamine along with cocaine or crack cocaine. Reports of snorting, injecting and swallowing. First reports a few years ago in homeless sector but now mainly younger people.
Report 13
Local authority: Edinburgh
Reason for report: New trend
Drug: Heroin
Appearance: Unknown
Summary: Heroin, referred to as ‘scab’ reported as being available. Strength reported as a concern for inexperienced users.
Report 14
Local authority: Edinburgh
Reason for report: New trend
Drug: Synthetic cannabinoids
Appearance: Unknown
Summary: Adverse effects (unknown) of synthetic cannabinoids suspected to be cut with opioids.
Report 15
Local authority: Edinburgh
Reason for report: New trend, adverse effects
Drug: Various
Appearance: Unknown
Summary: Adverse effects (unknown) related to fake Valium, Xanax (alprazolam) and pregabalin.
Report 16
Local authority: Ayrshire and Arran
Reason for report: New trend, adverse effects
Drug: Bromazolam
Appearance: White crystalline powder
Summary: Reports of adverse effects after swallowing bromazolam powder.
Report 17
Local authority: Glasgow
Reason for report: Adverse effects
Drug: Pregabalin, polydrug use
Appearance: Red and white capsules with ‘signature’ branding
Summary: Cluster of near-fatal overdoses. Those affected reported the use of multiple substances including alcohol, cocaine, benzodiazepines, gabapentin, opioid substitution therapy drugs and pregabalin. Several (not all) reported the use of pregabalin matching the alert – see national report 2.
Report 18
Local authority: Dumfries and Galloway
Reason for report: New drug
Drug: Pregabalin
Appearance: Red and white capsules with ‘signature’ branding
Summary: Reports of pregabalin use in the region.
Report 19
Local authority: Aberdeen City, Aberdeenshire and Moray
Reason for report: Adverse effects
Drug: Unknown, injecting
Appearance: Unknown
Summary: Slightly higher than average reports of bacterial infections in people who inject drugs.
Report 20
Local authority: Aberdeen
Reason for report: New drug, adverse effects
Drug: Pregabalin
Appearance: Red and white capsules with ‘signature’ branding
Summary: Drug service clients reporting use of illicit pregabalin called ‘signature’.
Report 21
Local authority: Highland
Reason for report: Adverse effects, suspected death
Drug: Pregabalin
Appearance: Red and white capsules with ‘signature’ branding
Summary: Capsules, thought to be pregabalin, found at the scene of a death where polydrug use suspected to be involved.
Report 22
Local authority: Aberdeen
Reason for report: Adverse effects
Drug: Pregabalin
Appearance: Red and white capsules with ‘signature’ branding
Summary: Adverse effects after swallowing four capsules – over-sedated (passed out for 13 hours), overdose, loss of consciousness, memory loss, confusion, low mood, physical injury and unusual behaviour. Purchased in blister packet from street dealer.
Report 23
Local authority: Aberdeen
Reason for report: Adverse effects
Drug: Crack cocaine
Appearance: Unknown
Summary: Significant concerns related to crack cocaine. Adverse effects in multiple clients – memory problems, paranoia, psychosis and unusual behaviour. Reported to be due to a change in the way crack cocaine is cut. Some clients report crack cut with mephedrone (referred to as ‘magic’ and ‘crunch’).
Reporting drug harms
The information in the regional breakdown can be used by local areas for their own drug trend surveillance. Please encourage people and services in your area to share information on trends, incidents and harms related to drugs, such as:
- adverse effects including overdose
- routes of administration
- new substances or patterns of use
- testing data.
Anyone can make a report by using our reporting form or by emailing phs.drugsradar@phs.scot